US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Matthew Harrison

Recent news which mentions Matthew Harrison

Why This Sarepta Therapeutics Is Turning Bullish
Tickers SRPT
Tags Price Target Matthew Harrison Upgrades
From Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
Tickers BIIB
Tags Geoff Meacham Brian Abrahams Ami Fadia
From Benzinga
Moderna Has Multi-Billion-Dollar Opportunity Outside Of COVID-19 Vaccines, Analyst Says
Tickers MRNA
Tags Analyst Ratings Market News Benzinga
From Benzinga
3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries
Tickers ADGI AZN GSK LLY
Tags Top Stories ADGI LLY
From Benzinga
Can Moderna Deliver A Highly Effective Flu Vaccine?
Tickers MRNA
Tags Market News Analyst Color Reiteration
From Benzinga